WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

Phase 2

Active, not recruiting

Conditions: T-Cell Lymphoma

Interventions: Drug: Duvelisib
Procedure: Peripheral blood draw

First Posted Date: 2020-04-02

Last Posted Date: 2024-07-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT04331119

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1

Active, not recruiting

Conditions: Triple Negative Breast Cancer

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Biological: Nivolumab
Procedure: Tumor biopsy
Biological: Cabiralizumab
Procedure: Bone marrow
Procedure: Blood draw

First Posted Date: 2020-04-02

Last Posted Date: 2024-05-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT04331067

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions

Recruiting

Conditions: Peripheral Pulmonary Nodules

Interventions: Device: BF-P190 4 mm thin bronchoscope
Device: BF-MP190F 3 mm ultrathin bronchoscope
Device: Radial ultrasound probe (UM S20-17S)
Device: PeriView FLEX 21G Single Use Aspiration Needle

First Posted Date: 2020-04-02

Last Posted Date: 2024-05-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT04331587

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

Phase 2

Recruiting

Conditions: Cancer of the Pancreas
Pancreas Cancer
Pancreas Adenocarcinoma

Interventions: Device: Adaptive stereotactic body radiation therapy
Procedure: Research blood draw
Drug: Defactinib
Procedure: Tumor biopsy

First Posted Date: 2020-04-02

Last Posted Date: 2024-07-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT04331041

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies

Completed

Conditions: Symptom Monitoring
Radiation Therapy

Interventions: Other: Noona Software

First Posted Date: 2020-03-27

Last Posted Date: 2022-04-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 36

Registration Number: NCT04324645

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Implementation of Ultrasound Guided Central Venous Catheter Confirmation Protocol

Recruiting

Conditions: Process, Acceptance
Inertia of Accommodation
Behavior

First Posted Date: 2020-03-27

Last Posted Date: 2023-12-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 120

Registration Number: NCT04324762

Locations: 🇺🇸
Washington Unversity School Of Medicine, Saint Louis, Missouri, United States

Mechanomyography for Predictor of Prognosis in CuTS and PND Patients

Completed

Conditions: Cubital Tunnel Syndrome
Peroneal Nerve Entrapment

Interventions: Device: Mechanomyography (MMG)

First Posted Date: 2020-03-26

Last Posted Date: 2024-02-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23

Registration Number: NCT04322448

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Vigabatrin and Insulin Sensitivity

Phase 2

Completed

Conditions: NAFLD
Obesity

Interventions: Drug: Vigabatrin

First Posted Date: 2020-03-25

Last Posted Date: 2024-07-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 4

Registration Number: NCT04321395

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

Phase 2

Recruiting

Conditions: Mucosal Melanoma of the Head and Neck

Interventions: Drug: Pembrolizumab
Radiation: Hypofractionated radiation therapy

First Posted Date: 2020-03-24

Last Posted Date: 2024-12-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT04318717

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Music and Local Anesthesia During Dermatologic Procedures

Not Applicable

Completed

Conditions: Pain
Anxiety

Interventions: Other: Music

First Posted Date: 2020-03-23

Last Posted Date: 2020-03-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT04317170

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy